Abstract | OBJECTIVE: METHODS: RESULTS: The serum levels of ALT (30.13 ± 4.12 U/L), AST (133.75 ± 21.18 U/L), HA (322.49 ± 52.33 µg/L) and LN (23.89 ± 5.03 µg/L) were lower in the HGF + INS group than those in the NS group (all P < 0.01); the scores of hepatic fibrosis stages (1.63 ± 0.74) and collagen semiquantitative of Masson stain (10.17 ± 1.14 × 10(-2)) were significantly reduced in the HGF + INS group than those in the NS group (all P < 0.01). CONCLUSION: The injection of hepatotrophic factors through portal vein after portacaval shunt can improve hepatic functions, reduce the damages of hepatocyte and improve the degree of hepatic fibrosis.
|
Authors | Peng Jiang, Jing-Ming Zhao, Zhong-Tao Zhang |
Journal | Zhonghua yi xue za zhi
(Zhonghua Yi Xue Za Zhi)
Vol. 90
Issue 48
Pg. 3440-3
(Dec 28 2010)
ISSN: 0376-2491 [Print] China |
PMID | 21223822
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Insulin
- Hepatocyte Growth Factor
|
Topics |
- Animals
- Disease Models, Animal
- Fibrosis
- Hepatocyte Growth Factor
(pharmacology)
- Hypertension, Portal
(physiopathology, surgery)
- Insulin
(pharmacology)
- Liver
(drug effects, pathology)
- Male
- Portacaval Shunt, Surgical
- Portal Vein
- Postoperative Period
- Rats
- Rats, Sprague-Dawley
|